SV

Street Verdict

Analyst Scorecard

A record of what Citi Analysis said publicly, with the source. Not advice.

Pending — not yet graded
“Citi views the recent correction in Divi's Laboratories as a buying opportunity, projecting a 28% upside for the stock. This indicates a bullish outlook on the company's shares.”

Citi Analysis’s track record (trackable calls only): 53 graded calls · 95% CI 40–66%

Divi's LaboratoriesBullishCalled 22 Aug 2025
Verdict:PENDING

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Read the original articleSee Citi Analysis’s full track record